Literature DB >> 3805774

Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa.

C S Goodwin, E Blincow, G Peterson, C Sanderson, W Cheng, B Marshall, J R Warren, R McCulloch.   

Abstract

Antibody to Campylobacter pyloridis was measured by ELISA in the sera of 160 patients from whom gastric biopsy specimens were also obtained. The antigen was an acid-glycine extract of C. pyloridis, and titers ranged from 80 to 22,000 ELISA units (EU). Of 117 patients in whom C. pyloridis was detected microbiologically or histologically, 87 (74%) had a titer greater than or equal to 300 EU, and only one had a titer less than 150 EU. Of 43 patients in whom C. pyloridis was not detected, only two (5%) had a titer greater than 300 EU. Thus, for a titer of 300 EU the ELISA test had a specificity of 97% and a sensitivity of 81%. At 150 EU the specificity was 78%, and the sensitivity was 99%. Histological diagnosis of active chronic gastritis was associated with a high median ELISA titer (485 E), chronic gastritis with a much lower titer (150 EU), and normal histology with a titer of 110 EU. Discriminating use of this serological test could be of assistance to detect C. pyloridis in the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3805774     DOI: 10.1093/infdis/155.3.488

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  64 in total

Review 1.  An assessment of serological tests for detection of Helicobacter pylori.

Authors:  H von Wulffen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

2.  Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection.

Authors:  Y Glupczynski; A Burette; H Goossens; C DePrez; J P Butzler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

3.  Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

4.  Elevated risk of Helicobacter pylori infection in submarine crews.

Authors:  I Hammermeister; G Janus; F Schamarowski; M Rudolf; E Jacobs; M Kist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

5.  Serum antibody against Helicobacter pylori assayed by a new capture ELISA.

Authors:  H Nakata; H Itoh; Y Yokoya; J Kawai; S Nishioka; K Miyamoto; N Kitamoto; H Miyamoto; T Tanaka
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

6.  Helicobacter pylori expresses a complex surface carbohydrate, Lewis X.

Authors:  R Sherburne; D E Taylor
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; J Reid; P Boothmann; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

8.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

9.  Naturally occurring chronic gastritis and C pylori infection in the rhesus monkey: a potential model for gastritis in man.

Authors:  A Baskerville; D G Newell
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

10.  Value of whole-cell antigen extracts for serologic detection of Helicobacter pylori.

Authors:  S M Salama; J N Wefuan; S Shiro-Koulla; A Mbakop; M Tagni-Sartre; E C Ndam; J L Ngu; D E Taylor
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.